91822-41-2Relevant articles and documents
Structure-activity relationship study of E6 as a novel necroptosis inducer
Mou, Jianfeng,Park, Ann,Cai, Yu,Yuan, Junying,Yuan, Chengye
supporting information, p. 3057 - 3061 (2015/06/22)
Necroptosis inducers represent a promising potential treatment for drug-resistant cancer. We herein describe the structure modification of E6, which was identified recently as a potent and selective necroptosis inducer. The studies described herein demonstrate for the first time that functionalized biphenyl derivatives possess necroptosis inducer activity. Furthermore, these studies have led to the identification of two promising compounds (5h and 5j) that can be used for further optimization studies as well as mechanism of action investigations.
Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof
-
, (2008/06/13)
The present invention relates to a compound with aryl-amidines, particularly amidinoaryl-cyclopropanes, amidinoarylmethyl-pyrroles, amidinoaryl-benzenes, amidinoaryl-pyridines, or amindonoaryl-alanines, represented by formula (1), a pharmaceutically acceptable salt, a prodrug, a hydrate, a solvate or an isomer thereof, which are inhibitors of coagulation enzyme, factor Xa (FXa). The present invention also relates to a pharmaceutical composition containing the compound, and a method of using the same as an anticoagulant agent for treatment and prevention of thrombosis disorders.
FUSED PYRIMIDINE COMPOUNDS AND THEIR USE AS PHARMACEUTICALS
-
, (2008/06/13)
Pharmaceutical compounds which are azolo-fused pyrimidine compounds having the formula STR1 in which =A--B--together with the pyrimidine ring forms a) a pyrazolo[1,5-a]pyrimidine of formula (A), STR2 b) a [1,2,4]triazolo[1,5-a]pyrimidine of formula (B), STR3 c) an imidazo[1,5-a]pyrimidine of formula (C), STR4 or d) an imidazo[1, 2-a]pyrimidine of formula (D), STR5